Theravance Biopharma Inc Financial Flexibility Index
Theravance Biopharma Inc financial flexibility index. Theravance Biopharma Inc (0TB) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of €-6.51 Million (operating CF €-6.51 Million minus capex €0.00) represents 0% of total liabilities (€182.78 Million). See 0TB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Theravance Biopharma Inc (2014–2024)
Financial flexibility index of Theravance Biopharma Inc from 2014 to 2024. Historical Financial Flexibility Index trend for Theravance Biopharma Inc across 11 annual periods. Check Theravance Biopharma Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Theravance Biopharma Inc Financial Flexibility Index by Year (2014–2024)
Theravance Biopharma Inc financial flexibility index by year from 2014 to 2024. Year-by-year free cash flow to debt coverage for Theravance Biopharma Inc. For the full cash flow conversion analysis, see 0TB cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.06x | €-11.20 Million | €-11.54 Million | €178.62 Million | ▲ +56.8% |
| 2023 | -0.15x | €-24.51 Million | €-27.00 Million | €169.00 Million | ▲ +87.1% |
| 2022 | -1.13x | €-186.42 Million | €-186.99 Million | €165.60 Million | ▼ -292.8% |
| 2021 | -0.29x | €-204.45 Million | €-207.86 Million | €713.39 Million | ▲ +9.2% |
| 2020 | -0.32x | €-243.79 Million | €-250.40 Million | €772.81 Million | ▲ +15.1% |
| 2019 | -0.37x | €-235.02 Million | €-238.20 Million | €632.67 Million | ▼ -115.2% |
| 2018 | -0.17x | €-105.63 Million | €-112.87 Million | €611.82 Million | ▲ +71.6% |
| 2017 | -0.61x | €-198.65 Million | €-201.05 Million | €326.22 Million | ▼ -81.7% |
| 2016 | -0.34x | €-96.85 Million | €-98.99 Million | €289.02 Million | ▲ +88.5% |
| 2015 | -2.91x | €-166.21 Million | €-168.86 Million | €57.05 Million | ▲ +18.7% |
| 2014 | -3.59x | €-172.05 Million | €-175.16 Million | €47.98 Million | — |